
Current Price | $75.31 | Mkt Cap | $1.3B |
---|---|---|---|
Open | $72.00 | P/E Ratio | 59.34 |
Prev. Close | $75.31 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $71.05 - $75.40 | Volume | 129,165 |
52-Wk Range | $44.26 - $85.70 | Avg. Daily Vol. | 107,114 |
Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.
Current Price | $75.31 | Mkt Cap | $1.3B |
---|---|---|---|
Open | $72.00 | P/E Ratio | 59.34 |
Prev. Close | $75.31 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $71.05 - $75.40 | Volume | 129,165 |
52-Wk Range | $44.26 - $85.70 | Avg. Daily Vol. | 107,114 |
The best Bull and Bear pitches based on recency and number of recommendations.
zzlangerhans (99.58) wrote: Outperform on LGND with a limit of 1.6. Here's my pitch: Ligand Pharmaceuticals has a pipeline and business model that resembles a mid-to-large cap biotech but a market cap of less than 200M. Their financial position and… More
For years I couldn't understand why Ligand wasn't getting any love for their deep and extensive pipeline that had led to many approved drugs. Then after seeing revenues fail to materialize quarter after quarter, I understood that the company was… More
Read the most recent pitches from players about LGND.
Recs
Great business model.
Recs
Biotech company that makes technology, not drugs. Technology gets sold to companies that make the drugs. Those companies pay LGND royalties. Love the business model.
Recs
TMF pick. Top AAPL-like stocks (along with PXD and SHOP)
Find the members with the highest scoring picks in LGND.
RaviDesai (< 20) Score: +979.29
The Score Leader is the player with the highest score across all their picks in LGND.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
imabugger | 42.89 | 12/15/2010 |
![]() |
5Y | $8.52 | +780.28% | +244.14% | +536.14 | 1 Comment | |
kkotwani | 28.92 | 6/22/2010 |
![]() |
5Y | $8.88 | +744.59% | +285.88% | +458.71 | 0 Comment | |
aaplover | 41.80 | 5/20/2010 |
![]() |
5Y | $9.06 | +727.81% | +292.71% | +435.10 | 0 Comment | |
germanjuggler | 69.46 |
|
![]() |
5Y | $10.19 | +636.02% | +222.28% | +413.73 | 1 Comment | |
investor2688 | < 20 | 9/21/2010 |
![]() |
5Y | $9.54 | +686.16% | +274.67% | +411.49 | 0 Comment | |
alt251 | 64.02 | 6/18/2010 |
![]() |
5Y | $9.48 | +691.14% | +282.95% | +408.19 | 0 Comment | |
luisitopower | < 20 | 5/20/2010 |
![]() |
5Y | $9.42 | +696.18% | +291.52% | +404.65 | 0 Comment | |
AllStarPortfolio | 21.41 | 5/19/2010 |
![]() |
5Y | $9.54 | +686.16% | +283.91% | +402.25 | 1 Comment | |
tehpirateguy | < 20 | 9/14/2010 |
![]() |
5Y | $9.72 | +671.60% | +279.92% | +391.68 | 0 Comment | |
bruceedge | < 20 | 6/20/2011 |
![]() |
5Y | $10.28 | +629.57% | +238.22% | +391.36 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.